Financial Performance - In 2025, the company achieved a revenue of CNY 2.407 billion, a year-on-year increase of 4.16% [3] - Net profit reached CNY 719 million, reflecting a growth of 10.77% compared to the previous year [3] - Operating cash flow net amount was CNY 962 million, also up by 9.62% year-on-year [3] - The gross margin of main products increased by 3.49 percentage points year-on-year [3] Business Segments - The color sorting machine business generated CNY 1.753 billion in revenue, growing by 8.05% year-on-year [3] - Export revenue for color sorting machines was CNY 564 million, with a year-on-year increase of 9.78% [3] - The medical business saw a decline in revenue to CNY 454 million, down 9.75% year-on-year, but the decline rate has significantly narrowed compared to the previous year [3] Strategic Focus - The company plans to continue implementing its development strategy, focusing on core industries and optimizing operational strategies for sustainable high-quality growth in 2026 [3] - The color sorting machine business benefits from enhanced product competitiveness and continuous investment in marketing [4] - The company integrates advanced technologies such as AI and IoT into its products, launching several intelligent sorting machines in 2025 [4] Market Outlook - The domestic dental industry is currently in a downturn due to economic conditions and market competition, but the company remains optimistic about its future [7][10] - The company has been expanding its overseas medical sales network since 2020, achieving good export performance for its medical products [11] Profit Distribution - The company has maintained a consistent profit distribution policy, with nearly CNY 4.9 billion in cash dividends distributed since its listing in 2012 [14] - The proposed cash dividend for 2025 is CNY 7 per share, with no stock dividends or capital reserve conversions [15]

Investment Rating - The report maintains a "Buy" rating for the company, expecting a relative performance increase of over 15% against the benchmark index within the next 6 to 12 months [17]. Core Insights - The company reported a revenue of 2,407 million yuan for 2025, reflecting a year-on-year growth of 4.16%, and a net profit attributable to shareholders of 719 million yuan, which is a 10.77% increase year-on-year [4][5]. - The company has shown significant improvement in profitability, with a gross margin of 53.92% in 2025, up by 3.49 percentage points year-on-year, and a net profit margin of 29.88%, increasing by 1.79 percentage points year-on-year [6][7]. - The company is focusing on technological innovation in the dental medical field, launching new products and applications, and is optimistic about future growth despite current market challenges [12]. Summary by Relevant Sections Financial Performance - In 2025, the company achieved a revenue of 2,407 million yuan, with a projected revenue growth rate of 14% for 2026 [3][4]. - The net profit for 2025 was 719 million yuan, with an expected growth of 18% in 2026 [3][4]. - The earnings per share (EPS) for 2025 is projected at 0.82 yuan, with an increase to 0.96 yuan in 2026 [3][4]. Profitability Analysis - The company’s gross margin improved to 53.92% in 2025, driven by enhanced production efficiency and a favorable product mix [6][7]. - The net profit margin also increased, indicating better cost management and operational efficiency [7]. Operational Efficiency - Inventory turnover days decreased to 97.28 days, and accounts receivable turnover days improved to 63.33 days, reflecting better sales channel optimization and inventory management [8]. - The company’s operating cash flow reached 9.62 billion yuan, indicating a steady improvement in operational quality [8]. Research and Development - The company invested 164 million yuan in R&D in 2025, representing 6.81% of its revenue, and holds a significant number of patents, indicating a strong commitment to innovation [8][12]. Market Position and Growth Potential - The company is a leader in the color sorting machine industry, with a revenue of 1,753 million yuan in 2025, growing by 8.05% year-on-year [9]. - The dental medical segment, while currently facing challenges, is expected to recover, with the company continuing to invest in this area [12]. Future Outlook - The company anticipates a net profit of 846 million yuan in 2026, with a growth rate of 17.64%, and further growth projected for 2027 and 2028 [13]. - The demand for color sorting machines remains robust, and the dental sector is expected to provide long-term growth opportunities [13].

Investment Rating - The report maintains a "Buy" rating for the company, expecting a relative performance increase of over 15% against the benchmark index in the next 6 to 12 months [17]. Core Insights - The company reported a revenue of 2.407 billion yuan for 2025, reflecting a year-on-year growth of 4.16%, and a net profit attributable to shareholders of 719 million yuan, up 10.77% year-on-year [4][5]. - The company has shown significant improvement in profitability, with a gross margin of 53.92%, an increase of 3.49 percentage points year-on-year, and a net profit margin of 29.88%, up 1.79 percentage points year-on-year [7]. - The company is focusing on technological innovation in the dental medical field, launching new products and applications, and is optimistic about future growth despite current market challenges [12]. Financial Performance Summary - Revenue and Profit Forecast: - 2024A: Revenue of 2.311 billion yuan, net profit of 649 million yuan - 2025A: Revenue of 2.407 billion yuan, net profit of 719 million yuan - 2026E: Revenue of 2.749 billion yuan, net profit of 846 million yuan - 2027E: Revenue of 3.112 billion yuan, net profit of 981 million yuan - 2028E: Revenue of 3.485 billion yuan, net profit of 1.127 billion yuan [3][14]. - Growth Rates: - Revenue growth rates are projected at -5% for 2024, 4% for 2025, and 14% for 2026, with net profit growth rates at -13% for 2024, 11% for 2025, and 18% for 2026 [3][14]. Operational Efficiency - The company has improved its inventory turnover days to 97.28 days, a decrease of 12.28 days year-on-year, and accounts receivable turnover days to 63.33 days, down 16.41 days year-on-year, indicating better sales channel optimization and cost control [8]. - The company’s R&D investment reached 164 million yuan in 2025, accounting for 6.81% of revenue, with a slight decrease of 0.09 percentage points year-on-year [8]. Market Position and Product Development - The color sorting machine segment continues to grow steadily, with revenue reaching 1.753 billion yuan in 2025, an increase of 8.05% year-on-year, and a gross margin of 54.26%, up 4.62 percentage points [9]. - The company is a pioneer in the domestic color sorting industry, focusing on innovation and expanding its product applications across various sectors [9]. Future Outlook - The company is optimistic about the dental medical market despite current downturns, with a projected revenue of 454 million yuan from medical equipment in 2025, although this represents a decline of 9.75% year-on-year [12]. - The introduction of the "Meiya Dental Health Digital Cloud Platform" aims to enhance operational efficiency and is expected to contribute to revenue growth as AI applications develop [13].

Investment Rating - The report maintains an "Accumulate" rating for the company with a target price of RMB 25.60 [6][7]. Core Views - The company has shown improvement in profit quality and is expected to benefit from a recovery in the industry [1]. - The color sorting machine business is experiencing rapid growth, while the revenue from dental medical equipment has reached a bottom [2]. - The gross profit margin for CBCT has rebounded, and the overall net profit margin has stabilized [3]. - There has been a significant improvement in cash flow, with net cash flow from operating activities increasing by 125% year-on-year [4]. - The company is optimistic about the growth potential of its color sorting machine business and the recovery of the CBCT business, maintaining profit forecasts for 2025 [5]. Summary by Sections Financial Performance - In H1 2025, the company achieved revenue of RMB 1.023 billion, a year-on-year increase of 9.92%, and a net profit of RMB 303 million, up 11.34% year-on-year [1]. - The gross profit margin for the first half of the year was 52.14%, with a net profit margin of 29.61%, reflecting a year-on-year increase of 1.26 percentage points and 0.38 percentage points, respectively [3]. Business Segments - The color sorting machine business saw a revenue increase of 15.2% year-on-year, while the medical equipment segment experienced a slight decline of 0.5% [2]. - The company has made significant strides in digital transformation within the dental medical sector, with over 10,000 users on its "Meiya Meiya" digital health platform by the end of June [2]. Cash Flow and Working Capital - The net cash flow from operating activities reached RMB 393 million, which is higher than the net profit, marking the first time since 2017 that this has occurred [4]. - Accounts receivable and inventory decreased year-on-year, indicating improved operational efficiency and industry leverage [4]. Profit Forecast and Valuation - The company forecasts net profits of RMB 700 million, RMB 744 million, and RMB 789 million for 2025, 2026, and 2027, respectively [5]. - The report assigns a PE ratio of 32 times for 2025, reflecting a target price adjustment based on comparable company valuations [5].